David M Kelley, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Williamstown Road, Lanesboro, MA 01237 Phone: 413-442-7007 Fax: 413-442-7011 |
James R Brennan, P.T, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 55 Williamstown Road, Lanesboro, MA 01237 Phone: 413-442-7007 Fax: 413-442-7011 |
Lisa M Baumgart, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 55 Williamstown Road, Lanesboro, MA 01237 Phone: 413-442-7007 Fax: 413-442-7011 |
Ms. Deborah Margaret Gerard, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Williamstown Rd., Greylock Physical Therapy, Lanesboro, MA 01237 Phone: 413-442-7007 |
Greylock Physical Therapy, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 31 Williamstown Rd, Lanesboro, MA 01237 Phone: 413-442-7007 Fax: 413-442-7011 |
Ms. Sandra C Knox, BS PT Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 55 Williamstown Rd, Lanesboro, MA 01237 Phone: 413-442-7007 Fax: 413-442-7011 |
News Archive
The New York Times: "An aide to the (Senate Finance) Committee said Monday that (the six senators trying to forge bipartisanship on a health care reform bill) would hold a teleconference call this week. Senators Max Baucus, Democrat of Montana and the committee chairman, and Sen. Charles E. Grassley of Iowa, the ranking Republican, have talked many times during the recess, the aide said. But the call will mark the entire group's first discussion since the recess began" (Seelye, 8/18).
A collaborative study published today in the journal Cell Reports provides evidence for a new molecular cause for neurodegeneration in Alzheimer's disease.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
A unique worldwide collaborative project takes advantage of the Internet to improve the accuracy of screening for rare metabolic disorders in newborns, reports a paper in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIRâ„¢. Kiadis Pharma's lead program, ATIRâ„¢, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.
› Verified 3 days ago